Where does Opko Biologics Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Opko Biologics Ltd. ranks #11,034 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Opko Biologics Ltd. hold?

Opko Biologics Ltd. holds 28 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Opko Biologics Ltd.'s Innovation Score?

Opko Biologics Ltd. has an Innovation Score of 33.1 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Opko Biologics Ltd. focus on?

Opko Biologics Ltd.'s top technology area is C07K (Peptides) with 25 patents, ranking #390 of 3,615 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Opko Biologics Ltd.'s patent grant rate increasing or decreasing?

Opko Biologics Ltd.'s recent grant velocity is -58% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Opko Biologics Ltd.'s patents?

Opko Biologics Ltd.'s patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Opko Biologics Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Opko Biologics Ltd.

USPTO PatentsView assignee record - 28 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Opko ranks #11,034 of 49,997 tracked US assignees by granted-patent volume, with 28 patents across 6 technology areas.

#11,034
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.1/100): 18.9
avg claims per patent: -58%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11034 · Foreign Corporation #11,034 · 28 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 28 grants
UPPER-Q #11,034/49,997
PHOTO-FINISH Next Silicon
CPC-NARROW C07K · 6 areas
INNOV-THIN 33.1/100
CLAIMS-RICH 18.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -58% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Next Silicon Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Opko’s 33.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.6 pts (35%) Velocity 1.5 pts (5%) Breadth 8.7 pts (26%) Claim depth 11.3 pts (34%)

Qualcomm Incorporated · highest

85
Amphenol East Asia… · near

33
Mtek-smart · near

33
NIO Nextev · near

33
Olympus Imaging · near

33
Opko Biologics · this assignee

33
3D Lighting… · lowest

7

What this shows Opko's Innovation Score is 33.1/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Opko?

Each dot is one of Opko’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Opko’s own 18.9 claims/patent is ABOVE the 16.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Opko vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Opko's grants concentrate

Opko Biologics Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 89.3% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (7 grants) versus a trough of 2 in 2015. By volume, Opko sits between Next Silicon Ltd and Opel Solar, Inc..

Opko's three-year grant acceleration

Opko Biologics Ltd. shows 2 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Next Silicon

28
Nucana

28
O2 Partners

28
Ondal Medical Sys…

28
Orexo AB

28
Orthosoft

28
Onanon

28
Opel Solar

28
Opko Biologics ◀

28

What this shows Opko holds 28 patents at rank #11,029, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Opko

By rank, the assignees closest to #11,029 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Opko's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Opko, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Opko ranks #390 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

Amphenol East Asia Electronic Technology (Shenzhen) Co., Ltd. 33 Olympus Imaging Corp. 33 NIO Nextev Limited 33 Mtek-smart Corporation 33

Opko's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Opko Biologics Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	7.1%
2016	4	14.3%
2017	3	10.7%
2018	7	25.0%
2019	3	10.7%
2020	3	10.7%
2021	3	10.7%
2024	2	7.1%
2025partial year	1	3.6%

Which technologies does Opko Biologics Ltd. patent most?

C07K - Peptides 25

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 23

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 10

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C12Y - Enzymes 8

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Opko Biologics Ltd.'s patent record in context - here's where to go next.

Opko Biologics Ltd.'s lead technology class is C07K (Peptides), 89.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #11,034 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Opko Biologics Ltd. against Next Silicon Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.